Literature DB >> 22116469

Oxidative stress in phenylketonuria: future directions.

Júlio César Rocha1, Maria João Martins.   

Abstract

Phenylketonuria represents the most prevalent inborn error of amino acid metabolism. In early diagnosed patients adequate and continued dietary treatment results in a good neurologic outcome. Natural protein and phenylalanine-restricted diet, even if rich in fruits and vegetables, represents a serious risk for nutritional deficiencies, albeit universally accepted. In the last few years, a growing number of reports have been describing oxidative stress as a concern in phenylketonuric patients. The diet itself includes good sources of dietary antioxidants (phytochemicals, some vitamins and minerals) but also a risk factor for some deficiencies (selenium, zinc, ubiquinone-10 and L-carnitine). Additionally, the extreme stringency of the diet may impose a reduced synthesis of endogenous antioxidants (like ubiquinone-10 and glutathione). Furthermore, increased phenylalanine levels, and its metabolites, may enhance the endogenous synthesis of reactive species and free radicals and/or interfere with the endogenous synthesis of enzymatic antioxidants (like glutathione peroxidase). Therefore, oxidative stress will probably increase, mainly in late diagnosed patients or in those with bad metabolic control. Considering the known association between oxidative stress, obesity and cardiovascular disease, it seems advisable to look further to the impact of oxidative stress on body macromolecules and structures (like lipoprotein oxidation), especially in phenylketonuric patients with late diagnosis or bad metabolic control, in order to prevent future increased risks. Recommendations for PKU patient's clinical follow-up improvement and educational goals are included.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22116469     DOI: 10.1007/s10545-011-9417-2

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  94 in total

1.  Position of the American Dietetic Association: vegetarian diets.

Authors:  Winston J Craig; Ann Reed Mangels
Journal:  J Am Diet Assoc       Date:  2009-07

Review 2.  Diet and cancer--an overview.

Authors:  W C Willett; B MacMahon
Journal:  N Engl J Med       Date:  1984-03-08       Impact factor: 91.245

3.  Zinc decreases C-reactive protein, lipid peroxidation, and inflammatory cytokines in elderly subjects: a potential implication of zinc as an atheroprotective agent.

Authors:  Bin Bao; Ananda S Prasad; Frances W J Beck; James T Fitzgerald; Diane Snell; Ginny W Bao; Tapinder Singh; Lavoisier J Cardozo
Journal:  Am J Clin Nutr       Date:  2010-04-28       Impact factor: 7.045

4.  Plasma phenylalanine is associated with decreased serum ubiquinone-10 concentrations in phenylketonuria.

Authors:  R Artuch; C Colomé; M A Vilaseca; C Sierra; F J Cambra; N Lambruschini; J Campistol
Journal:  J Inherit Metab Dis       Date:  2001-06       Impact factor: 4.982

Review 5.  Future treatment strategies in phenylketonuria.

Authors:  Francjan J van Spronsen; Gregory M Enns
Journal:  Mol Genet Metab       Date:  2010       Impact factor: 4.797

6.  A longitudinal study of antioxidant status in phenylketonuric patients.

Authors:  Rafael Artuch; Catrina Colomé; Cristina Sierra; Nuria Brandi; Nilo Lambruschini; Jaume Campistol; Dolores Ugarte; Maria A Vilaseca
Journal:  Clin Biochem       Date:  2004-03       Impact factor: 3.281

7.  Effect of short- and long-term exposition to high phenylalanine blood levels on oxidative damage in phenylketonuric patients.

Authors:  Angela Sitta; Alethéa G Barschak; Marion Deon; Amanda T Barden; Giovana B Biancini; Paula R Vargas; Carolina F de Souza; Cristina Netto; Moacir Wajner; Carmen R Vargas
Journal:  Int J Dev Neurosci       Date:  2009-01-20       Impact factor: 2.457

Review 8.  Large neutral amino acids supplementation in phenylketonuric patients.

Authors:  J C Rocha; F Martel
Journal:  J Inherit Metab Dis       Date:  2009-05-13       Impact factor: 4.982

9.  Oxidized LDL and the metabolic syndrome.

Authors:  Paul Holvoet; Dieuwke De Keyzer; David R Jacobs
Journal:  Future Lipidol       Date:  2008-12

Review 10.  Antioxidant vitamins and their use in preventing cardiovascular disease.

Authors:  Dan Farbstein; Adena Kozak-Blickstein; Andrew P Levy
Journal:  Molecules       Date:  2010-11-09       Impact factor: 4.411

View more
  21 in total

Review 1.  Antioxidant treatment strategies for hyperphenylalaninemia.

Authors:  Priscila Nicolao Mazzola; George Albert Karikas; Kleopatra H Schulpis; Carlos Severo Dutra-Filho
Journal:  Metab Brain Dis       Date:  2013-05-09       Impact factor: 3.584

2.  Functional cobalamin (vitamin B12) deficiency: role of advanced age and disorders associated with increased oxidative stress.

Authors:  L R Solomon
Journal:  Eur J Clin Nutr       Date:  2015-01-07       Impact factor: 4.016

3.  Serum ischemia modified albumin is a possible new marker of oxidative stress in phenylketonuria.

Authors:  Fatemeh Keshavarzi; Mohsen Rastegar; Mahmood Vessal; Gholamreza Rafiei Dehbidi; Marjan Khorsand; Amir Hossein Ganjkarimi; Mohammad Ali Takhshid
Journal:  Metab Brain Dis       Date:  2017-12-21       Impact factor: 3.584

4.  Role of catalase and superoxide dismutase activities on oxidative stress in the brain of a phenylketonuria animal model and the effect of lipoic acid.

Authors:  Tarsila Barros Moraes; Carlos Eduardo Diaz Jacques; Andrea Pereira Rosa; Giovana Reche Dalazen; Melaine Terra; Juliana Gonzalez Coelho; Carlos Severo Dutra-Filho
Journal:  Cell Mol Neurobiol       Date:  2012-12-12       Impact factor: 5.046

5.  Effect of Blood Phenylalanine Levels on Oxidative Stress in Classical Phenylketonuric Patients.

Authors:  Burcu Kumru; Davut Sinan Kaplan; Burcu Oztürk Hismi; Hakim Celik
Journal:  Cell Mol Neurobiol       Date:  2017-12-28       Impact factor: 5.046

Review 6.  Phenylketonuria Pathophysiology: on the Role of Metabolic Alterations.

Authors:  Patrícia Fernanda Schuck; Fernanda Malgarin; José Henrique Cararo; Fabiola Cardoso; Emilio Luiz Streck; Gustavo Costa Ferreira
Journal:  Aging Dis       Date:  2015-10-01       Impact factor: 6.745

Review 7.  Oxidative stress in phenylketonuria-evidence from human studies and animal models, and possible implications for redox signaling.

Authors:  Vanessa Trindade Bortoluzzi; Carlos Severo Dutra Filho; Clovis Milton Duval Wannmacher
Journal:  Metab Brain Dis       Date:  2021-02-13       Impact factor: 3.584

8.  Protective effect of L-carnitine on Phenylalanine-induced DNA damage.

Authors:  Marion Deon; Sharon S Landgraf; Jessica F Lamberty; Dinara J Moura; Jenifer Saffi; Moacir Wajner; Carmen R Vargas
Journal:  Metab Brain Dis       Date:  2015-01-20       Impact factor: 3.584

9.  Protein substitutes for phenylketonuria in Europe: access and nutritional composition.

Authors:  M J Pena; M F de Almeida; E van Dam; K Ahring; A Bélanger-Quintana; K Dokoupil; H Gokmen-Ozel; A M Lammardo; A MacDonald; M Robert; J C Rocha
Journal:  Eur J Clin Nutr       Date:  2016-04-27       Impact factor: 4.016

10.  Inhibiting neutral amino acid transport for the treatment of phenylketonuria.

Authors:  Adam M Belanger; Malgorzata Przybylska; Estelle Gefteas; Matthew Furgerson; Sarah Geller; Alla Kloss; Seng H Cheng; Yunxiang Zhu; Nelson S Yew
Journal:  JCI Insight       Date:  2018-07-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.